<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>2007-7459</journal-id>
<journal-title><![CDATA[Horizonte sanitario]]></journal-title>
<abbrev-journal-title><![CDATA[Horiz. sanitario]]></abbrev-journal-title>
<issn>2007-7459</issn>
<publisher>
<publisher-name><![CDATA[Universidad Juárez Autónoma de Tabasco, División Académica de Ciencias de la Salud]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S2007-74592020000300415</article-id>
<article-id pub-id-type="doi">10.19136/hs.a19n3.3881</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Vacuna BCG e indicadores de mortalidad y morbilidad por COVID-19 en países con curva epidémica consolidada]]></article-title>
<article-title xml:lang="en"><![CDATA[TB vaccine and indicators of mortality and morbidity from COVID-19 in countries with a consolidated epidemic curve]]></article-title>
<article-title xml:lang="pt"><![CDATA[Vacina BCG e indicadores de mortalidade e morbidade por COVID-19 em países com curva epidêmica consolidada]]></article-title>
<article-title xml:lang="fr"><![CDATA[Vaccin BCG et indicateurs de mortalité et de morbidité dus au COVID-19 dans les pays à courbe épidémique consolidée]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Sánchez Barragán]]></surname>
<given-names><![CDATA[Baldómero]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Avalos García]]></surname>
<given-names><![CDATA[María Isabel]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Castillo Castillo]]></surname>
<given-names><![CDATA[Katia Alejandra]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[López Romero]]></surname>
<given-names><![CDATA[Samantha]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Sosa Marquina]]></surname>
<given-names><![CDATA[Jennifer Sofía]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Universidad Juárez Autónoma de Tabasco División Académica de Ciencias de la Salud ]]></institution>
<addr-line><![CDATA[Villahermosa Tabasco]]></addr-line>
<country>Mexico</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Universidad Juárez Autónoma de Tabasco División Académica de Ciencias de la Salud ]]></institution>
<addr-line><![CDATA[Villahermosa Tabasco]]></addr-line>
<country>Mexico</country>
</aff>
<aff id="Af3">
<institution><![CDATA[,Universidad Juárez Autónoma de Tabasco División Académica de Ciencias de la Salud ]]></institution>
<addr-line><![CDATA[Villahermosa Tabasco]]></addr-line>
<country>Mexico</country>
</aff>
<aff id="Af4">
<institution><![CDATA[,Universidad Juárez Autónoma de Tabasco División Académica de Ciencias de la Salud ]]></institution>
<addr-line><![CDATA[Villahermosa Tabasco]]></addr-line>
<country>Mexico</country>
</aff>
<aff id="Af5">
<institution><![CDATA[,Universidad Juárez Autónoma de Tabasco División Académica de Ciencias de la Salud ]]></institution>
<addr-line><![CDATA[Villahermosa Tabasco]]></addr-line>
<country>Mexico</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>12</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>12</month>
<year>2020</year>
</pub-date>
<volume>19</volume>
<numero>3</numero>
<fpage>415</fpage>
<lpage>426</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_arttext&amp;pid=S2007-74592020000300415&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_abstract&amp;pid=S2007-74592020000300415&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_pdf&amp;pid=S2007-74592020000300415&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen  Objetivo: Señalar posible influencia de coberturas de vacunación con bacilos Calmette-Guérin (BCG) en indicadores de mortalidad y morbilidad por COVID-19, en países con curva epidémica consolidada.  Materiales y Métodos:  Se trata de un estudio ecológico mixto, del total de países que integran la Organización Mundial de la Salud (OMS).Se eligieron aquellos con curva epidémica consolidada por COVID-19, actualizada al 1 de junio 2020 e información tomada de base de datos de vacunación 1980-2018 Estimates of National Immunization Coverage, ambas fuentes de OMS, contrastando las coberturas y políticas de vacunación universal e ingreso per cápita con letalidad, mortalidad e incidencia en 45 países que cumplieron con los criterios, aplicando medidas de asociación e impacto potencial: riesgo relativo(RR) reducción de riesgo(RDR), muertes prevenibles en vacunados(MEV%), casos prevenibles en vacunados(CEV%) con intervalo de confianza para tasas con 99% de significancia.  Resultados:  Países con coberturas mayor de 60% y política actual de vacunación universal, en contraste con países con cero% coberturas, con reducción de indicadores de mortalidad y morbilidad: Letalidad 5.8-9.7%, mortalidad 883.8-937 por 106 (p&lt;0.01) habitantes, incidencia 4,260-4,351.6 por 105 (p&lt;0.01) habitantes; incremento de: MEV% 94.1-99.8%(p&lt;0.01) y CEV% 96.9-99.6%(p&lt;0.01). El mayor contraste de indicadores fue para países con ingreso medio bajo e ingreso medio alto. Países con coberturas menor de 60% contra cero % coberturas (ambos grupos con altos ingresos) con reducción (excepto Letalidad): Letalidad-1.861 a -4.703 %(p&gt;0.01), mortalidad 774.3- 827.8 por 106 (p&lt;0.01) habitantes, incidencia 4,193.13- 4,212.93 por 105 (p&lt;0.01) habitantes, incremento de: MEV% 82.5-88.2%(p&lt;0.01), CEV% 96.0-96.5%(p&lt;0.01). También mayor diferencia de indicadores para países con coberturas cercanas al 60%, con política de vacunación universal actual.  Conclusiones:  Los países con coberturas de vacunación con BCG superior a 60% con mantenimiento de políticas de vacunación universal, tienen mayor reducción de indicadores de mortalidad, morbilidad por COVID-19 e incremento significativo de casos y muertes evitadas sugiriendo posible influencia por vacunación entre otros factores.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract   Objective:  Indicate the possible influence of vaccination coverage with Calmette-Guérin bacilli (BCG) on indicators of mortality andmorbidity from COVID-19 in countries with a consolidated epidemic curve. of association and potential impact: relative risk (RR)  Materials and methods:  This is a mixed ecological study of all the countries that make up the World Health Organization (WHO). Those with an epidemic curve consolidated by COVID-19 updated to June 1, 2020 and information taken from the vaccination database 1980-2018 Estimates of National Immunization Coverage, both sources of WHO, were chosen, contrasting the coverage and policies of universal vaccination and income per capita with lethality, mortality and incidence in 45 countries that met the criteria applying measures of association and potential impact: relative risk (RR), risk reduction (RDR), preventable deaths in vaccinated (MEV%), preventable cases in vaccinated (CEV%) with confidence interval for rates with 99% significance.  Results:  Countries with coverage greater than 60% and current universal vaccination policy in contrast to countries with zero% coverage, with reduction in mortality and morbidity indicators: Mortality 5.8-9.7%, mortality 883.8-937 per 106 (p &lt;0.01) inhabitants, incidence 4,260-4,351.6 per 105 (p &lt;0.01) inhabitants; Increase of: MEV% 94.1-99.8% (p &lt;0.01) and CEV% 96.9-99.6% (p &lt;0.01). The greatest contrast of indicators were for countries with lower middle income and upper middle income. Countries with coverage less than 60% versus zero% coverage (both groups with high incomes) with reduction (except case fatality): case fatality-1.861 to -4.703% (p&gt; 0.01), mortality774.3-827.8 per 106 (p &lt;0.01) inhabitants, incidence 4,193.13- 4,212.93 per 105 (p &lt;0.01) inhabitants, increase of: MEV% 82.5- 88.2% (p &lt;0.01), CEV% 96.0-96.5 (p &lt;0.01) .Also greater difference of indicators for countries with coverage close to 60% with current universal vaccination policy.  Conclusions: Countries with BCG vaccination coverage greater than 60% with maintenance of universal vaccination policies, have a greater reduction in mortality indicators, morbidity from COVID-19 and a significant increase in cases and deaths, suggesting possible influence by vaccination among other factors.]]></p></abstract>
<abstract abstract-type="short" xml:lang="pt"><p><![CDATA[Resumo   Objetivo:  Indique a possível influência da cobertura vacinal com bacilos de Calmette-Guérin (BCG) nos indicadores de mortalidade e morbidade do COVID-19 em países com uma curva epidêmica consolidada.  Materiais e métodos:  É um estudo ecológico misto do número total de países que compõem a Organização Mundial da Saúde (OMS). Aqueles com uma curva epidêmica consolidada pelo COVID-19 atualizada para 1º de junho de 2020 e informações retiradas do banco de dados de vacinação 1980-2018, foram escolhidas as Estimativas de Cobertura Nacional de Imunizações, ambas as fontes da OMS, contrastando a cobertura e as políticas de vacinação universal e renda. per capita com letalidade, mortalidade e incidência em 45 países que atenderam aos critérios de aplicação de possíveis medidas de associação e impacto: risco relativo(RR),redução de risco (RDR), mortes evitáveis em vacinados (MEV%), casos evitáveis em vacinados (CEV%) com intervalo de confiança para taxas com significância de 99%.  Resultados: Países com cobertura superior a 60% e política atual de vacinação universal em contraste com países com cobertura zero, com redução nos indicadores de mortalidade e morbidade: Mortalidade 5,8-9,7%, mortalidade 883.8-937 por 106 (p &lt;0,01) habitantes, incidência 4,260-4,351.6 por 105 (p &lt;0,01) habitantes; Aumento de: MEV% 94.1-99.8% (p &lt;0,01) e CEV% 96.9-99.6% (p &lt;0,01). O maior contraste de indicadores ocorreu nos países com renda média baixa e renda média alta. Países com cobertura inferior a 60% versus zero% (ambos os grupos com renda alta) com redução (exceto casos fatais): casos fatalidade -1.861 a -4.703 % (p&gt; 0,01), mortalidade 774.3-827.8 por 106 habitantes (p &lt;0,01), incidência 4,193.13- 4,212.93 por 105 (p &lt;0,01) habitantes, aumento de: MEV% 82.5-88.2 % (p&lt;0,01), CEV% 96.0-96.5% (p &lt;0,01). Também maior diferença de indicadores para países com cobertura perto de 60% com a atual política universal de vacinação.  Conclusões:  Os países com cobertura vacinal para BCG superior a 60% com manutenção de políticas universais de vacinação apresentam maior redução nos indicadores de mortalidade, morbidade por COVID-19 e um aumento significativo de casos e mortes evitaram sugerir uma possível influência através da vacinação, entre outros fatores.]]></p></abstract>
<abstract abstract-type="short" xml:lang="fr"><p><![CDATA[résumé est disponible dans le document]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Vacuna BCG]]></kwd>
<kwd lng="es"><![CDATA[mortalidad]]></kwd>
<kwd lng="es"><![CDATA[morbilidad]]></kwd>
<kwd lng="es"><![CDATA[COVID-19]]></kwd>
<kwd lng="en"><![CDATA[BCG vaccine]]></kwd>
<kwd lng="en"><![CDATA[mortality]]></kwd>
<kwd lng="en"><![CDATA[morbidity]]></kwd>
<kwd lng="en"><![CDATA[COVID-19]]></kwd>
<kwd lng="pt"><![CDATA[vacina BCG]]></kwd>
<kwd lng="pt"><![CDATA[mortalidade]]></kwd>
<kwd lng="pt"><![CDATA[morbidade]]></kwd>
<kwd lng="pt"><![CDATA[COVID-19]]></kwd>
<kwd lng="fr"><![CDATA[vaccin BCG]]></kwd>
<kwd lng="fr"><![CDATA[mortalité]]></kwd>
<kwd lng="fr"><![CDATA[morbidité]]></kwd>
<kwd lng="fr"><![CDATA[COVID-19.]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Huang]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Wang]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Li]]></surname>
<given-names><![CDATA[X]]></given-names>
</name>
<name>
<surname><![CDATA[Ren]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Zhao]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Hu]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China]]></article-title>
<source><![CDATA[Lancet]]></source>
<year>2020</year>
<volume>395</volume>
<numero>10223</numero>
<issue>10223</issue>
<page-range>497-506</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kamps]]></surname>
<given-names><![CDATA[BS]]></given-names>
</name>
<name>
<surname><![CDATA[Hoffmann]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<source><![CDATA[Covid Reference]]></source>
<year>2020</year>
<edition>4ta</edition>
<page-range>1-376</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="">
<collab>Organización Mundial de la Salud</collab>
<source><![CDATA[COVID-19: cronología de la actuación de la OMS]]></source>
<year>2020</year>
</nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Zhu]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Zhang]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Wang]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[Li]]></surname>
<given-names><![CDATA[X]]></given-names>
</name>
<name>
<surname><![CDATA[Yang]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Song]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A novel coronavirus from patients with pneumonia in China, 2019]]></article-title>
<source><![CDATA[N Engl J Med]]></source>
<year>2020</year>
<volume>382</volume>
<numero>8</numero>
<issue>8</issue>
<page-range>727-33</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="">
<collab>World Health Organization</collab>
<source><![CDATA[Coronavirus disease (COVID-19). 2020;(June)]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="">
<collab>Secretaría de Salud</collab>
<source><![CDATA[Dirección General de Epidemiología. Octavo Informe Epidemiológico de la Situación de COVID-19]]></source>
<year>2020</year>
</nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="">
<collab>Secretaría de Salud</collab>
<source><![CDATA[Dirección General de Epidemiología. Comunicado Técnico Diario COVID-19,2020/06/13]]></source>
<year>2020</year>
</nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="">
<collab>Secretaría de Salud</collab>
<source><![CDATA[Dirección General de Epidemiología. COVID-19: Mapa interactivo de México, casos y tasas]]></source>
<year>2020</year>
</nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Abdallah]]></surname>
<given-names><![CDATA[Abdallah]]></given-names>
</name>
<name>
<surname><![CDATA[Behr]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Evolution and Strain Variation in BCG]]></article-title>
<source><![CDATA[Strain Var Mycobacterium Tuberc Complex Its Role Biol Epidemiol Control]]></source>
<year>2017</year>
</nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Butkeviciute]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Jones]]></surname>
<given-names><![CDATA[CE]]></given-names>
</name>
<name>
<surname><![CDATA[Smith]]></surname>
<given-names><![CDATA[SG]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Heterologous effects of infant BCG vaccination: Potential mechanisms of immunity]]></article-title>
<source><![CDATA[Future Microbiol]]></source>
<year>2018</year>
<volume>13</volume>
<numero>10</numero>
<issue>10</issue>
<page-range>1193-208</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Moorlag]]></surname>
<given-names><![CDATA[SJCFM]]></given-names>
</name>
<name>
<surname><![CDATA[Arts]]></surname>
<given-names><![CDATA[RJW]]></given-names>
</name>
<name>
<surname><![CDATA[van Crevel R]]></surname>
<given-names><![CDATA[NM]]></given-names>
</name>
</person-group>
<source><![CDATA[Non-specific effects of BCG vaccine on viral infections]]></source>
<year>2019</year>
<volume>12</volume>
<page-range>1473-8</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Arts]]></surname>
<given-names><![CDATA[RJW]]></given-names>
</name>
<name>
<surname><![CDATA[Moorlag]]></surname>
<given-names><![CDATA[SJCFM]]></given-names>
</name>
<name>
<surname><![CDATA[Novakovic]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Li]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Wang]]></surname>
<given-names><![CDATA[SY]]></given-names>
</name>
<name>
<surname><![CDATA[Oosting]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[BCG Vaccination Protects against Experimental Viral Infection in Humans through the Induction of Cytokines Associated with Trained Immunity]]></article-title>
<source><![CDATA[Cell Host Microbe]]></source>
<year>2018</year>
<volume>23</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>89-100.e5</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[de Bree]]></surname>
<given-names><![CDATA[LCJ]]></given-names>
</name>
<name>
<surname><![CDATA[Koeken]]></surname>
<given-names><![CDATA[VACM]]></given-names>
</name>
<name>
<surname><![CDATA[Joosten]]></surname>
<given-names><![CDATA[LAB]]></given-names>
</name>
<name>
<surname><![CDATA[Aaby]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Benn]]></surname>
<given-names><![CDATA[CS]]></given-names>
</name>
<name>
<surname><![CDATA[van Crevel]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Non-specific effects of vaccines: Current evidence and potential implications]]></article-title>
<source><![CDATA[Semin Immunol]]></source>
<year>2018</year>
<volume>39</volume>
<page-range>35-43</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hollm-Delgado]]></surname>
<given-names><![CDATA[MG]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Acute Lower Respiratory Infection Among Bacille Calmette-Guérin (BCG)-Vaccinated Children]]></article-title>
<source><![CDATA[Pediatrics]]></source>
<year>2014</year>
<volume>133</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>e73-81</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[dos Santos]]></surname>
<given-names><![CDATA[JC]]></given-names>
</name>
<name>
<surname><![CDATA[Vilela Teodoro Silva]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Ribeiro- Dias]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Joosten]]></surname>
<given-names><![CDATA[LAB]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Non-specific effects of BCG in protozoal infections: tegumentary leishmaniasis and malaria]]></article-title>
<source><![CDATA[Clin Microbiol Infect]]></source>
<year>2019</year>
<volume>25</volume>
<numero>12</numero>
<issue>12</issue>
<page-range>1479-83</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Komine-Aizawa]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Yamazaki]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Yamazaki]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Hattori]]></surname>
<given-names><![CDATA[S-I]]></given-names>
</name>
<name>
<surname><![CDATA[Miyamoto]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Yamamoto]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Influence of advanced age on Mycobacterium bovis BCG vaccination in guinea pigs aerogenically infected with Mycobacterium tuberculosis.]]></article-title>
<source><![CDATA[Clin Vaccine Immunol]]></source>
<year>2010</year>
<volume>17</volume>
<numero>10</numero>
<issue>10</issue>
<page-range>1500-6</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Datau]]></surname>
<given-names><![CDATA[EA]]></given-names>
</name>
<name>
<surname><![CDATA[Sultana]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Mandang VV]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Jim]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The Efficacy of Bacillus Calmette-Guérin Vaccinations for The Prevention of Acute Upper Respiratory Tract Infection in The Elderly]]></article-title>
<source><![CDATA[Acta Med Indones]]></source>
<year>2011</year>
<page-range>185-90</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hegarty]]></surname>
<given-names><![CDATA[PK]]></given-names>
</name>
<name>
<surname><![CDATA[Sfakianos]]></surname>
<given-names><![CDATA[JP]]></given-names>
</name>
<name>
<surname><![CDATA[Giannarini]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Dinardo]]></surname>
<given-names><![CDATA[AR]]></given-names>
</name>
<name>
<surname><![CDATA[Kamat]]></surname>
<given-names><![CDATA[AM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[COVID-19 and Bacillus Calmette-Guérin :What is the Link ?]]></article-title>
<source><![CDATA[Eur Urol Oncol]]></source>
<year>2020</year>
<volume>3</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>259-61</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[M]]></surname>
<given-names><![CDATA[Gursel]]></given-names>
</name>
<name>
<surname><![CDATA[IG]]></surname>
<given-names><![CDATA[Is]]></given-names>
</name>
</person-group>
<source><![CDATA[global BCG vaccination coverage relevant to the progression of SARS-CoV-2 pandemic?]]></source>
<year>2020</year>
</nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Miller]]></surname>
<given-names><![CDATA[Aaron]]></given-names>
</name>
<name>
<surname><![CDATA[Reandelar]]></surname>
<given-names><![CDATA[Mac Josh]]></given-names>
</name>
<name>
<surname><![CDATA[Fasciglione]]></surname>
<given-names><![CDATA[Kimberly]]></given-names>
</name>
<name>
<surname><![CDATA[Roumenova]]></surname>
<given-names><![CDATA[Violeta]]></given-names>
</name>
<name>
<surname><![CDATA[Li]]></surname>
<given-names><![CDATA[Yan]]></given-names>
</name>
</person-group>
<collab>GHO</collab>
<article-title xml:lang=""><![CDATA[Correlation between universal BCG vaccination policy and reduced morbidity and mortality for COVID-19]]></article-title>
<source><![CDATA[an epidemiological study. Psychol Appl to Work An Introd to Ind Organ Psychol Tenth Ed Paul]]></source>
<year>2012</year>
<volume>53</volume>
<numero>9</numero>
<issue>9</issue>
<page-range>1689-99</page-range></nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ozdemir]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Kucuksezer]]></surname>
<given-names><![CDATA[UC]]></given-names>
</name>
<name>
<surname><![CDATA[Tamay]]></surname>
<given-names><![CDATA[ZU]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Is BCG vaccination effecting the spread and severity of COVID&#8208;19?]]></article-title>
<source><![CDATA[Allergy]]></source>
<year>2020</year>
<page-range>1-3</page-range></nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Curtis]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Sparrow]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Ghebreyesus]]></surname>
<given-names><![CDATA[TA]]></given-names>
</name>
<name>
<surname><![CDATA[Netea]]></surname>
<given-names><![CDATA[MG.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Considering BCG vaccination to reduce the impact of COVID-19.]]></article-title>
<source><![CDATA[Lancet]]></source>
<year>2020</year>
<volume>395</volume>
<numero>10236</numero>
<issue>10236</issue>
<page-range>1545-6</page-range></nlm-citation>
</ref>
<ref id="B23">
<label>23</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Redelman-Sidi]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Could BCG be used to protect against COVID-19?]]></article-title>
<source><![CDATA[Nat Rev Urol]]></source>
<year>2020</year>
</nlm-citation>
</ref>
<ref id="B24">
<label>24</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rajarshi]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Chatterjee]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Ray]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[BCG vaccination strategy implemented to reduce the impact of COVID-19 : Hype or Hope ?]]></article-title>
<source><![CDATA[Med Drug Discov]]></source>
<year>2020</year>
<volume>7</volume>
</nlm-citation>
</ref>
<ref id="B25">
<label>25</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bosch]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Bosch]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<source><![CDATA[ClinicaTrials.gov Search Results]]></source>
<year>2020</year>
<page-range>7-8</page-range></nlm-citation>
</ref>
<ref id="B26">
<label>26</label><nlm-citation citation-type="">
<collab>World Health Organization</collab>
<source><![CDATA[COVID-19 Situation in WHO - Western Pacific Region. Last updated]]></source>
<year>2020</year>
</nlm-citation>
</ref>
<ref id="B27">
<label>27</label><nlm-citation citation-type="">
<collab>World Health Organization</collab>
<source><![CDATA[COVID-19 situation in the WHO European Region. data as of:]]></source>
<year>2020</year>
</nlm-citation>
</ref>
<ref id="B28">
<label>28</label><nlm-citation citation-type="">
<collab>World Health Organization</collab>
<source><![CDATA[United Nations Children´s Fund. Estimates of National Immunization Coverage]]></source>
<year>2019</year>
</nlm-citation>
</ref>
<ref id="B29">
<label>29</label><nlm-citation citation-type="">
<collab>Public Health Agency of Canada</collab>
<source><![CDATA[THE BCG WORLD ATLAS: A DATABASE OF GLOBAL BCG VACCINATION POLICIES AND PRACTICES [Internet]. 2nd Editio. 2017.]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B30">
<label>30</label><nlm-citation citation-type="">
<collab>Banco Mundial</collab>
<source><![CDATA[PIB per cápita (US$ a precios actuales). Datos sobre las cuentas nacionales del Banco Mundial y archivos de datos sobre cuentas nacionales de la OCDE]]></source>
<year>2018</year>
</nlm-citation>
</ref>
<ref id="B31">
<label>31</label><nlm-citation citation-type="">
<collab>Expansión/Datosmacro.com</collab>
<source><![CDATA[Economía y datos de los países]]></source>
<year>2020</year>
</nlm-citation>
</ref>
<ref id="B32">
<label>32</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Dever Alan]]></surname>
<given-names><![CDATA[G.E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Mediciones epidemiológicas. Capítulo 4]]></article-title>
<source><![CDATA[Epidemiología y Administración de Servicios de Salud]]></source>
<year>1991</year>
<page-range>77-115</page-range><publisher-name><![CDATA[Organización Panamericana de la Salud/ Organización Mundial de la Salud]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B33">
<label>33</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Berg]]></surname>
<given-names><![CDATA[MK]]></given-names>
</name>
<name>
<surname><![CDATA[Yu]]></surname>
<given-names><![CDATA[Q]]></given-names>
</name>
<name>
<surname><![CDATA[Salvador]]></surname>
<given-names><![CDATA[CE]]></given-names>
</name>
<name>
<surname><![CDATA[Melani]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Kitayama]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<source><![CDATA[Mandated Bacillus Calmette-Guérin (BCG) vaccination predicts flattened curves for the spread of COVID-]]></source>
<year>2020</year>
</nlm-citation>
</ref>
<ref id="B34">
<label>34</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Fidel Jr]]></surname>
<given-names><![CDATA[PL]]></given-names>
</name>
<name>
<surname><![CDATA[Noverr]]></surname>
<given-names><![CDATA[MC]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Could an unrelated live attenuated vaccine serve as a preventive measure to dampen septic inflammation associated with COVID-19 infection?]]></article-title>
<source><![CDATA[mBio]]></source>
<year>2020</year>
</nlm-citation>
</ref>
<ref id="B35">
<label>35</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kaufmann]]></surname>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[BCG Educates Hematopoietic Stem Cells to GenerateProtectiveInnate Immunity against Tuberculosis]]></article-title>
<source><![CDATA[Cell]]></source>
<year>2018</year>
<volume>172</volume>
<page-range>176-90</page-range></nlm-citation>
</ref>
<ref id="B36">
<label>36</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Perlmutter]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Kristin]]></surname>
<given-names><![CDATA[Loberg]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Incendio intestinal y cerebral Capítulo 2]]></article-title>
<source><![CDATA[Alimenta tu cerebro]]></source>
<year>2018</year>
<page-range>57-89</page-range><publisher-name><![CDATA[Editorial Grijalbo vital]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B37">
<label>37</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Khan]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Mendonca]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Dhariwal]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Intestinal dysbiosis compromises alveolar macrophage immunity to Mycobacterium tuberculosis]]></article-title>
<source><![CDATA[Mucosal Immunol]]></source>
<year>2019</year>
<volume>12</volume>
<page-range>772-83</page-range></nlm-citation>
</ref>
<ref id="B38">
<label>38</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Dhar]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Mohanty]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Gut microbiota and Covid-19- possible link and implications]]></article-title>
<source><![CDATA[Virus Research]]></source>
<year>2020</year>
<volume>285</volume>
<page-range>198018</page-range></nlm-citation>
</ref>
<ref id="B39">
<label>39</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Manjili]]></surname>
<given-names><![CDATA[RH]]></given-names>
</name>
<name>
<surname><![CDATA[Zarei]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Habibi]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Manjilix]]></surname>
<given-names><![CDATA[MH]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[COVID-19 as an Acute Inflammatory Disease]]></article-title>
<source><![CDATA[The Journal of Immunology]]></source>
<year>2020</year>
<volume>205</volume>
<page-range>12-9</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
